Emtriva and Prezcobix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emtriva (emtricitabine) and Prezcobix (cobicistat; darunavir ethanolate). Common drug interactions include hyperkalaemia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Emtriva and Prezcobix. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.

What is Prezcobix?

Prezcobix has active ingredients of cobicistat; darunavir ethanolate. eHealthMe is studying from 2,113 Prezcobix users. Check the latest studies of Prezcobix.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

68 people who take Emtriva and Prezcobix together, and have interactions are studied.

Emtriva and Prezcobix drug interactions.

What are the common drug interactions of Emtriva and Prezcobix, by gender? *:

female:

  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  3. Bone density decreased
  4. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  5. Mobility decreased (ability to move is reduced)
  6. Osteonecrosis (death of bone)
  7. Osteoporosis (bones weak and more likely to break)
  8. Arthralgia (joint pain)
  9. Bone loss
  10. Drug ineffective

male:

  1. Emotional distress
  2. Pain
  3. Osteoporosis (bones weak and more likely to break)
  4. Quality of life decreased
  5. Renal impairment (severely reduced kidney function)
  6. Blood creatinine increased
  7. Bone density decreased
  8. Osteonecrosis (death of bone)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Drug ineffective

What are the common drug interactions of Emtriva and Prezcobix, by age (0-1 to 60+)? *:

0-1:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Asthenia (weakness)
  4. Blood creatinine increased
  5. Body height decreased
  6. Bone pain
  7. Emotional distress
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Osteopenia (a condition where bone mineral density is lower than normal)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Emotional distress
  3. Pain
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Depression
  6. Bone density decreased
  7. Osteoporosis (bones weak and more likely to break)
  8. Blood creatinine increased
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

40-49:

  1. Renal impairment (severely reduced kidney function)
  2. Anaemia (lack of blood)
  3. Decreased activity
  4. Osteoporosis (bones weak and more likely to break)
  5. Blood creatinine increased
  6. Depression
  7. Drug ineffective
  8. Dysuria (painful or difficult urination)
  9. Fall
  10. Foot fracture

50-59:

  1. Pain
  2. Chronic kidney disease
  3. Emotional distress
  4. Anxiety
  5. Renal failure (kidney dysfunction)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Depression
  8. Osteonecrosis (death of bone)
  9. Bone loss
  10. Drug ineffective

60+:

  1. Chronic kidney disease
  2. Emotional distress
  3. Blood creatinine increased
  4. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  5. Gait disturbance
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Renal impairment (severely reduced kidney function)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  10. Bone density decreased

What are the existing conditions these people have? *

  1. Hiv Infection: 66 people, 97.06%
  2. Pain: 9 people, 13.24%
  3. High Blood Pressure: 8 people, 11.76%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 11.76%
  5. High Blood Cholesterol: 6 people, 8.82%
  6. Hypersensitivity: 5 people, 7.35%
  7. Herpes Virus Infection: 5 people, 7.35%
  8. Diabetes: 5 people, 7.35%
  9. Depression: 5 people, 7.35%
  10. Asthma: 5 people, 7.35%

* Approximation only. Some reports may have incomplete information.

Do you take Emtriva and Prezcobix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Emtriva and Prezcobix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prezcobix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emtriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prezcobix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine and cobicistat; darunavir ethanolate (the active ingredients of Emtriva and Prezcobix, respectively), and Emtriva and Prezcobix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: